Search Results

There are 11956 results for: content related to: Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel study

  1. You have free access to this content
    Buprenorphine for treating cancer pain

    Intervention Review

    The Cochrane Library

    Mia Schmidt-Hansen, Nathan Bromham, Mark Taubert, Stephanie Arnold and Jennifer S Hilgart

    Published Online : 31 MAR 2015, DOI: 10.1002/14651858.CD009596.pub4

  2. You have free access to this content
    Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

    Intervention Review

    The Cochrane Library

    Richard P Mattick, Courtney Breen, Jo Kimber and Marina Davoli

    Published Online : 6 FEB 2014, DOI: 10.1002/14651858.CD002207.pub4

  3. Buprenorphine for the management of opioid withdrawal

    Intervention Review

    The Cochrane Library

    Linda Gowing, Robert Ali and Jason M White

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD002025.pub4

  4. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

    Addiction

    Volume 105, Issue 4, April 2010, Pages: 709–718, Sandra D. Comer, Maria A. Sullivan, Suzanne K. Vosburg, Jeanne Manubay, Leslie Amass, Ziva D. Cooper, Phillip Saccone and Herbert D. Kleber

    Version of Record online : 10 MAR 2010, DOI: 10.1111/j.1360-0443.2009.02843.x

    Corrected by:

    Erratum

    Vol. 105, Issue 7, 1322, Version of Record online: 8 JUN 2010

  5. Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose-Escalation Trials

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 179–192, Dr Domenic A. Ciraulo, Dr Robert J. Hitzemann, Dr Eugene Somoza, Dr Clifford M. Knapp, Dr John Rotrosen, Dr Ofra Sarid-Segal, Ms Ann Marie Ciraulo, Dr David J. Greenblatt and Dr C. Nora Chiang

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005284192

  6. The clinical use of buprenorphine in opiate addiction: evidence and practice

    Acta Neuropsychiatrica

    Volume 16, Issue 5, October 2004, Pages: 246–274, Fergus D. Law, Judy S. Myles, Mark R. C. Daglish and David J. Nutt

    Version of Record online : 11 FEB 2005, DOI: 10.1111/j.0924-2708.2004.00095.x

  7. Buprenorphine-Based Regimens and Methadone for the Medical Management of Opioid Dependence: Selecting the Appropriate Drug for Treatment

    The American Journal on Addictions

    Volume 19, Issue 6, November-December 2010, Pages: 557–568, Icro Maremmani and Gilberto Gerra

    Version of Record online : 21 SEP 2010, DOI: 10.1111/j.1521-0391.2010.00086.x

  8. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine

    European Journal of Pain

    Volume 13, Issue 3, March 2009, Pages: 219–230, Hans G. Kress

    Version of Record online : 9 JAN 2012, DOI: 10.1016/j.ejpain.2008.04.011

  9. Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile

    Pain Practice

    Volume 10, Issue 5, September/October 2010, Pages: 428–450, Joseph Pergolizzi, Anna Maria Aloisi, Albert Dahan, Joerg Filitz, Richard Langford, Rudolf Likar, Sebastiano Mercadante, Bart Morlion, Robert B. Raffa, Rainer Sabatowski, Paola Sacerdote, Luis M. Torres and Avi A. Weinbroum

    Version of Record online : 17 MAY 2010, DOI: 10.1111/j.1533-2500.2010.00378.x

  10. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

    The Milbank Quarterly

    Volume 93, Issue 3, September 2015, Pages: 561–583, BRADLEY D. STEIN, ROSALIE LICCARDO PACULA, ADAM J. GORDON, RACHEL M. BURNS, DOUGLAS L. LESLIE, MARK J. SORBERO, SEBASTIAN BAUHOFF, TODD W. MANDELL and ANDREW W. DICK

    Version of Record online : 8 SEP 2015, DOI: 10.1111/1468-0009.12137

  11. You have free access to this content
    Post-marketing Surveillance of Methadone and Buprenorphine in the United States

    Pain Medicine

    Volume 11, Issue 7, July 2010, Pages: 1078–1091, Nabarun Dasgupta, Elise J. Bailey, Theodore Cicero, James Inciardi, Mark Parrino, Andrew Rosenblum and Richard C. Dart

    Version of Record online : 8 JUN 2010, DOI: 10.1111/j.1526-4637.2010.00877.x

  12. Buprenorphine in Maintenance Treatment: Experience among Italian Physicians in Drug Addiction Centers

    The American Journal on Addictions

    Volume 19, Issue 3, May-June 2010, Pages: 222–230, Gianluca Quaglio, Cristian Pattaro, Gilberto Gerra, Paolo Mezzelani, Linda Montanari, Don C. Des Jarlais and Fabio Lugoboni

    Version of Record online : 2 APR 2010, DOI: 10.1111/j.1521-0391.2010.00040.x

  13. Correlations of Maternal Buprenorphine Dose, Buprenorphine, and Metabolite Concentrations in Meconium With Neonatal Outcomes

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 5, November 2008, Pages: 604–612, SL Kacinko, HE Jones, RE Johnson, RE Choo and MA Huestis

    Version of Record online : 13 AUG 2008, DOI: 10.1038/clpt.2008.156

  14. Buprenorphine TTS for children – a review of the drug’s clinical pharmacology

    Pediatric Anesthesia

    Volume 21, Issue 3, March 2011, Pages: 280–290, Erik Michel, Brian J Anderson and Boris Zernikow

    Version of Record online : 21 NOV 2010, DOI: 10.1111/j.1460-9592.2010.03437.x

  15. Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses

    Veterinary Anaesthesia and Analgesia

    Volume 42, Issue 1, January 2015, Pages: 17–29, Emma J Love, Ludovic Pelligand, Polly M Taylor, Joanna C Murrell and John W Sear

    Version of Record online : 16 APR 2014, DOI: 10.1111/vaa.12165

  16. Bringing Buprenorphine-Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience

    The American Journal on Addictions

    Volume 13, Issue S1, May-June 2004, Pages: S42–S66, Leslie Amass, Walter Ling, Thomas E. Freese, Chris Reiber, Jeffrey J. Annon, Allan J. Cohen, Dennis McCarty, Malcolm S. Reid, Lawrence S. Brown Jr., Cynthia Clark, Douglas M. Ziedonis, Jonathan Krejci, Susan Stine, Theresa Winhusen, Greg Brigham, Dean Babcock, Joan A. Muir, Betty J. Buchan and Terry Horton

    Version of Record online : 18 FEB 2010, DOI: 10.1080/10550490490440807

  17. The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers

    Addiction

    Volume 106, Issue 8, August 2011, Pages: 1460–1473, Lisa S. Middleton, Paul A. Nuzzo, Michelle R. Lofwall, David E. Moody and Sharon L. Walsh

    Version of Record online : 3 MAY 2011, DOI: 10.1111/j.1360-0443.2011.03424.x

  18. You have free access to this content
    The clinical analgesic efficacy of buprenorphine

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 6, December 2014, Pages: 577–583, R. B. Raffa, M. Haidery, H.-M. Huang, K. Kalladeen, D. E. Lockstein, H. Ono, M. J. Shope, O. A. Sowunmi, J. K. Tran and J. V. Pergolizzi Jr

    Version of Record online : 29 JUL 2014, DOI: 10.1111/jcpt.12196

  19. The history of the development of buprenorphine as an addiction therapeutic

    Annals of the New York Academy of Sciences

    Volume 1248, Issue 1, February 2012, Pages: 124–139, Nancy D. Campbell and Anne M. Lovell

    Version of Record online : 18 JAN 2012, DOI: 10.1111/j.1749-6632.2011.06352.x

  20. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment

    Addiction

    Volume 102, Issue 4, April 2007, Pages: 616–622, Suzanne Nielsen, Paul Dietze, Nicole Lee, Adrian Dunlop and David Taylor

    Version of Record online : 7 FEB 2007, DOI: 10.1111/j.1360-0443.2006.01731.x